Table 3 Sample Characteristics
|
P-ICD 10-positive(N = 132) No. (%) |
P-ICD 10-negative(N = 133) No. (%) | P-value | |
|---|---|---|---|
| Sex | |||
| Male | 49 (37) | 44 (33) | |
| Female | 83 (63) | 89 (67) | |
| Age | |||
| > 70 | 36 (27) | 30 (23) | |
| 61-70 | 33 (25) | 28 (21) | |
| 51-60 | 37 (28) | 44 (33) | |
| 41-50 | 16 (12) | 21 (16) | |
| 31-40 | 8 (6) | 6 (5) | |
| < 30 | 1 (1) | 2 (2) | |
| Education | |||
| Did not receive education | 24 (18) | 16 (12) | |
| Elementary | 42 (32) | 43 (32) | |
| high school | 36 (27) | 38 (29) | |
| College | 25 (19) | 29 (22) | |
| College graduate | 1 (1) | 4 (3) | |
| Missing | 4 | 3 | |
| Cancer diagnosis | |||
| Head & Neck | 9 | 12 | |
| Lung & Mediastinum | 12 | 16 | |
| Breast | 39 | 58 | 0.033* |
| Liver | 5 | 5 | |
| GI tract(except liver) | 29 | 15 | 0.035* |
| GU tract | 6 | 3 | |
| GYN | 8 | 9 | |
| Prostate | 7 | 2 | |
| Hematological malignancy | 2 | 0 | |
| Others | 10 | 13 | |
| Missing | 2 | 3 | |
| Treatment Modalities | |||
| Palliative treatment | 77 | 51 | 0.022* |
| Curative treatment | 18 | 38 | 0.088* |
| F/U after curative treatment | 35 | 43 | |
| Condition of the Disease | 23 | 0 | |
| No signs and symptoms | 30 | 51 | 0.02* |
| Stationary state | 13 | 20 | |
| Progression (local invasion) | 35 | 18 | 0.02* |
| Progression (Metastasis) | 28 | 15 | 0.047* |
| Terminal stage | 27 | 21 | |
| Missing | 5 | 2 |